Kwang Woo Ahn Selected Research

Kwang Woo Ahn Research Topics

Disease

8	Leukemia 07/2022 - 06/2012
7	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 05/2013
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2021 - 07/2014
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2020 - 04/2012
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2022 - 01/2016
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 05/2013
4	Neoplasms (Cancer) 01/2022 - 09/2012
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 03/2014
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2018 - 12/2013
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 05/2013
3	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 05/2013
3	Infections 01/2021 - 01/2019
2	Primary Myelofibrosis (Myelosclerosis) 12/2020 - 01/2014
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2017 - 06/2012
2	Bronchiolitis Obliterans Syndrome 09/2017 - 04/2015
2	Lymphoma (Lymphomas) 10/2016 - 09/2015
1	Pneumonia (Pneumonitis) 01/2022
1	Obesity 01/2022
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022
1	Cryptogenic Organizing Pneumonia 01/2022
1	Hemorrhage 01/2022
1	Residual Neoplasm 01/2021
1	COVID-19 01/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Sepsis (Septicemia) 01/2020
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2019
1	Wilms Tumor (Wilm's Tumor) 10/2018
1	Multiple Myeloma 08/2017
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 05/2017
1	Large Granular Lymphocytic Leukemia 05/2017
1	Aplastic Anemia (Anemia, Hypoplastic) 05/2016
1	Hypertension (High Blood Pressure) 06/2014
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2013
1	Autoimmune Diseases (Autoimmune Disease) 10/2012
1	Polycythemia Vera 09/2012
1	Inborn Errors Metabolism (Inborn Errors of Metabolism) 09/2012
1	Primary Immunodeficiency Diseases 09/2012
1	Essential Thrombocythemia 09/2012
1	Splenomegaly 09/2012
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 09/2012

Drug/Important Bio-Agent (IBA)

6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 12/2013
4	Busulfan (Busulfex)FDA Link 11/2021 - 12/2013
3	Calcineurin InhibitorsIBA 01/2018 - 10/2016
3	Rituximab (Mabthera)FDA Link 01/2018 - 12/2015
3	HLA Antigens (Human Leukocyte Antigens)IBA 09/2014 - 12/2013
2	fludarabineIBA 11/2021 - 01/2018
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Melphalan (Alkeran)FDA LinkGeneric 11/2021
1	CI 22IBA 01/2019
1	AntigensIBA 01/2018
1	Amino Acids FDA Link 01/2018
1	fms-Like Tyrosine Kinase 3IBA 10/2016
1	Glucose (Dextrose)FDA LinkGeneric 09/2015
1	Biological ProductsIBA 06/2014
1	A 7 (A-7)IBA 06/2012
1	Tyrosine Kinase InhibitorsIBA 04/2012

Therapy/Procedure

33	Cell Transplantation 01/2022 - 09/2012
17	Transplantation 07/2022 - 06/2012
9	Therapeutics 07/2022 - 10/2012
9	Homologous Transplantation 04/2021 - 05/2013
5	Hematopoietic Stem Cell Transplantation 10/2018 - 04/2015
4	Drug Therapy (Chemotherapy) 01/2022 - 04/2013
1	MDC protocol 01/2022
1	Indwelling Catheters (Indwelling Catheter) 01/2020
1	Autologous Transplantation 01/2018
1	Stem Cell Transplantation 05/2013
1	Splenectomy 09/2012